LC-MS/MS confirms that COX-1 drives vascular prostacyclin whilst gene expression pattern reveals non-vascular sites of COX-2 expression.
There are two schools of thought regarding the cyclooxygenase (COX) isoform active in the vasculature. Using urinary prostacyclin markers some groups have proposed that vascular COX-2 drives prostacyclin release. In contrast, we and others have found that COX-1, not COX-2, is responsible for vascula...
Main Authors: | Nicholas S Kirkby, Anne K Zaiss, Paula Urquhart, Jing Jiao, Philip J Austin, Malak Al-Yamani, Martina H Lundberg, Louise S MacKenzie, Timothy D Warner, Anna Nicolaou, Harvey R Herschman, Jane A Mitchell |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3711559?pdf=render |
Similar Items
-
COX-2 protects against atherosclerosis independently of local vascular prostacyclin: identification of COX-2 associated pathways implicate Rgl1 and lymphocyte networks.
by: Nicholas S Kirkby, et al.
Published: (2014-01-01) -
Prostacyclin mediates endothelial COX-2-dependent neuroprotective effects during excitotoxic brain injury
by: An Y, et al.
Published: (2014-05-01) -
CYCLOOXYGENASE-1 (COX-1) AND BICISTRONIC COX-1/PROSTACYCLIN SYNTHASE GENE TRANSFER PROTECT AGAINST ISCHEMIC CEREBRAL INFARCTION
by: Lin Heng, et al.
Published: (2002) -
Reversible suppression of cyclooxygenase 2 (COX-2) expression in vivo by inducible RNA interference.
by: Anne K Zaiss, et al.
Published: (2014-01-01) -
Effects of COX-2 inhibition on expression of vascular endothelial growth factor and interleukin-8 in lung cancer cells
by: Yu Danny CW, et al.
Published: (2008-07-01)